Status epilepticus and the use of continuous EEG monitoring in the intensive care unit

CONTINUUM Lifelong Learning in Neurology

Volumn 18, Issue 3, 2012, Pages 560-578

  Bleck, Thomas P ^a  

^a RUSH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; BENZODIAZEPINE; CEFEPIME; DESFLURANE; DIAZEPAM; ETIRACETAM; ETOMIDATE; FOSPHENYTOIN SODIUM; HARKOSERIDE; IMMUNOGLOBULIN; ISOFLURANE; KETAMINE; LORAZEPAM; MIDAZOLAM; NORADRENALIN; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PROPOFOL; STEROID; TOPIRAMATE; VALPROIC ACID;

ACIDOSIS; ANTIBODY TITER; ANTICONVULSANT THERAPY; ASSISTED VENTILATION; AUTOIMMUNE DISEASE; BLOOD PRESSURE; BODY TEMPERATURE; BRAIN CORTEX; BRAIN EDEMA; CATHETER INFECTION; CEREBELLUM; COMPLEX PARTIAL SEIZURE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE CLEARANCE; CRITICALLY ILL PATIENT; DECUBITUS; DEEP VEIN THROMBOSIS; DELTA RHYTHM; DETERIORATION; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG MEGADOSE; EASTERN EQUINE ENCEPHALITIS; ELECTROENCEPHALOGRAPHY; ENDOTRACHEAL INTUBATION; EPILEPSY; EPILEPTIC STATE; GENERAL ANESTHESIA; GRAND MAL SEIZURE; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; HYPERTHERMIA; HYPOTENSION; HYPOVENTILATION; IMMUNE DEFICIENCY; INTENSIVE CARE UNIT; INTRACRANIAL PRESSURE; INTUBATION; LIVER TOXICITY; LOADING DRUG DOSE; LOW DRUG DOSE; LUMBAR PUNCTURE; LUNG EMBOLISM; METABOLIC ACIDOSIS; MOTOR ACTIVITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREATITIS; PATIENT MONITORING; PHLEBOGRAPHY; PLEOCYTOSIS; PNEUMONIA; POLYMERASE CHAIN REACTION; RECURRENT DISEASE; REHABILITATION CARE; REVIEW; RHABDOMYOLYSIS; SEDATION; SEIZURE; SIDE EFFECT; SIGNAL PROCESSING; SOMNOLENCE; STIMULUS RESPONSE; STROKE; SUBARACHNOID HEMORRHAGE; TACHYCARDIA; TACHYPHYLAXIS; THROMBOCYTOPENIA; TREATMENT FAILURE; UNITED STATES; URINARY TRACT INFECTION;

ANTICONVULSANTS; BRAIN EDEMA; DISEASE MANAGEMENT; ELECTROENCEPHALOGRAPHY; EMERGENCIES; HUMANS; INFECTION; INTENSIVE CARE; INTENSIVE CARE UNITS; LIFE SUPPORT CARE; MONITORING, PHYSIOLOGIC; RECURRENCE; STATUS EPILEPTICUS; THROMBOPHILIA;

EID: 84862156579     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000415428.61277.90     Document Type: Review

References (30)

1. Hirsch LJ, Brenner RP, Drislane FW, et al. The ACNS subcommittee on research terminology for continuous EEG monitoring: Proposed standardized terminology for rhythmic and periodic EEG patterns encountered in critically ill patients. J Clin Neurophysiol 2005;22(2):128-135.
2. Lowenstein DH, Bleck T, Macdonald RL. It's time to revise the definition of status epilepticus. Epilepsia 1999;40(1):120-122.
3. Shinnar S, Berg AT, Moshe SL, Shinnar R. How long do new-onset seizures in children last? Ann Neurol 2001;49(5):659-664.
4. Treiman DM. Electroclinical features of status epilepticus. J Clin Neurophysiol 1995; 12(4):343-362.
5. Vein AA, van Emde Boas W. Kozhevnikov epilepsy: The disease and its eponym. Epilepsia 2011;52(2):212-218.
6. Bleck TP, Smith MC, Pierre-Louis SJ, et al. Neurologic complications of critical medical illnesses. Crit Care Med 1993;21(1):98-103.
7. Wittman JJ Jr, Hirsch LJ. Continuous electroencephalogram monitoring in the critically ill. Neurocrit Care 2005;2(3): 330-341.
8. Friedman D, Claassen J, Hirsch LJ. Continuous electroencephalogram monitoring in the intensive care unit. Anesth Analg 2009;109(2): 506-523.
9. Waterhouse EJ, Garnett LK, Towne AR, et al. Prospective population-based study of intermittent and continuous convulsive status epilepticus in Richmond, Virginia. Epilepsia 1999;40(6):752-758.
10. Maganti R, Jolin D, Rishi D, Biswas A. Nonconvulsive status epilepticus due to cefepime in a patient with normal renal function. Epilepsy Behav 2006;8(1):312-314.
11. Bassin S, Bleck TP. Seizures in the critically ill. In: Vincent J-L, Abraham E, Moore FA, et al, editors. Textbook of critical care. 6th ed. New York, NY: Elsevier/Saunders, 2011: 203-211.
12. Bleck TP. Management approaches to prolonged seizures and status epilepticus. Epilepsia 1999;40(suppl 1):S59-S63; discussion S64-S66.
13. Brophy GM, Bell R, Claassen J, et al; Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Guidelines for the evaluation and management of status epilepticus [published online ahead of print April 24, 2012]. Neurocrit Care 2012. doi:10.1007/s12028-012-9695-z.
14. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998;339(12):792-798.
15. Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001; 345(9):631-637.
16. Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012;366(7):591-600.
17. Silbergleit R, Durkalski V, Lowenstein D, et al; Neurological Emergencies Treatment Trials Investigators. Randomized non-inferiority clinical trial of intramuscular midazolam versus intravenous lorazepam for out-of-hospital status epilepticus by paramedics. In press.
18. Bleck TP. Critical care of the patient in status epilepticus. In: Wasterlain C, Treiman D, editors. Status epilepticus. Boston, MA: MIT Press, 2006:607-613.
19. Alvarez V, Januel JM, Burnand B, Rossetti AO. Second-line status epilepticus treatment: Comparison of phenytoin, valproate, and levetiracetam. Epilepsia 2011;52(7):1292-1296.
20. Cock HR; ESETT Group. Established status epilepticus treatment trial (ESETT). Epilepsia 2011;52(suppl 8):50-52.
21. Kumar A, Bleck TP. Intravenous midazolam for the treatment of refractory status epilepticus. Crit Care Med 1992;20(4): 483-488.
22. Kramer AH. Early ketamine to treat refractory status epilepticus [published online ahead of print]. Neurocrit Care 2012;doi:10.1007/s12028-011- 9668-7.
23. Mirsattari SM, Sharpe MD, Young GB. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol 2004;61(8):1254-1259.
24. Prasad A, Worrall BB, Bertram EH, Bleck TP. Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia 2001;42(3):380-386.
25. Bleck TP. Hypothermia, hyperthermia, and other systemic factors in status epilepticus. Epilepsia 2009;50(suppl 12):10.
26. Drislane FW, Lopez MR, Blum AS, Schomer DL. Survivors and nonsurvivors of very prolonged status epilepticus. Epilepsy Behav 2011;22(2):342-345.
27. Crippen D, Burrows D, Stocchetti N, et al. Ethics roundtable debate: 'Open-ended ICU care: Canwe afford it?' Crit Care 2010;14(3):222.
28. Claassen J, Jetté N, Chum F, et al. Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology 2007;69(13):1356-1365.
29. Bleck TP. Less common etiologies of status epilepticus. Epilepsy Curr 2010;10(2):31-33.
30. Johnson N, Henry C, Fessler AJ, Dalmau J. Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus. Neurology 2010;75(16):1480-1482.